Dipti Sadalge

Company: Foghorn Therapeutics Inc.

Job title: Principal Scientist

Seminars:

Biochemical and Biophysical Characterization of Selective CBP Degraders 11:30 am

CBP and EP300 have a bidirectional Synthetic lethal relationship Selective inhibitors/ degraders of CBP (and EP300) are highly desired as dual inhibition exhibits hematopoietic toxicity Insights into Biochemical and Biophysical ternary complex assays to probe selectivity of CBP degradersRead more

day: Day 1